Updated Jul 16, 2026
Cini John K. is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
John K. Cini is the Chief Scientific Officer and a Director at Sonnet BioTherapeutics Holdings, Inc. He has been involved in the biotechnology sector, focusing on therapeutic development.
| Role | Director |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-04 | SONN | Sonnet BioTherapeutics Holdings, Inc. | D — Derivative transaction | 14.1K | — | |
| 2025-07-11 | SONN | Sonnet BioTherapeutics Holdings, Inc. | A — Grant or award | 12.0K | — | |
| 2024-12-05 | SONN | Sonnet BioTherapeutics Holdings, Inc. | A — Grant or award | 1.9K | — |
John K. Cini is the Chief Scientific Officer and a Director at Sonnet BioTherapeutics Holdings, Inc. He has been involved in the biotechnology sector, focusing on therapeutic development.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Cini John K. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.